Use of neboglamine (cr 2249) as an antipsychotic and...

Details Use of neboglamine (cr 2249) as an antipsychotic and... Use of neboglamine (cr 2249) as an antipsychotic and...

A - Human Necessities

61

K

A61K 31/196 (2006.01) A61K 31/13 (2006.01) A61P 25/18 (2006.01) A61P 25/24 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2567397

Use of neboglamine, (S)-4-amino-N-(4,4- dimethylcyclohexyl) glutamic acid (CR 2249) (CAS Registry Number 163000-63-3), of the racemate thereof or of a pharmaceutically acceptable salt thereof for the preparation of a medicament for the treatment of schizophrenia.

L'invention concerne l'utilisation de néboglamine, ou encore acide (S)-4-amino-N-(4,4- diméthylcyclohexyl) glutamique (CR 2249) (numéro de registre 163000-63-3 du Chemical Abstracts System (CAS)), ou du racémate correspondant ou d'un sel pharmaceutiquement acceptable correspondant, pour l'élaboration d'un médicament utilisé dans le traitement de la schizophrénie.

Affiliated with

Also associated with

Rating

Use of neboglamine (cr 2249) as an antipsychotic and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of neboglamine (cr 2249) as an antipsychotic and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of neboglamine (cr 2249) as an antipsychotic and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1409242